See more : Dhanuka Agritech Limited (DHANUKA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PT Millennium Pharmacon International Tbk (SDPC.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Millennium Pharmacon International Tbk, a leading company in the Medical – Distribution industry within the Healthcare sector.
- AXT, Inc. (AXTI) Income Statement Analysis – Financial Results
- JUTEC Holdings Corporation (3157.T) Income Statement Analysis – Financial Results
- Nexity Financial Corporation (NXTYQ) Income Statement Analysis – Financial Results
- Equites Property Fund Limited (EQU.JO) Income Statement Analysis – Financial Results
- Yangtzekiang Garment Limited (0294.HK) Income Statement Analysis – Financial Results
PT Millennium Pharmacon International Tbk (SDPC.JK)
About PT Millennium Pharmacon International Tbk
PT Millennium Pharmacon International Tbk engages in the distribution and trading of prescription and non-prescription medicines, dietary supplements, and medical devices in Indonesia. The company distributes its products through drug stores, pharmacies, hospitals, supermarkets, and retail shops. As of December 31, 2021, it operated 33 branch offices in Java, Bali, Sumatera, Kalimantan, and Sulawesi Islands. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium Pharmacon International Tbk is a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,363.52B | 3,200.83B | 2,988.85B | 2,643.63B | 2,726.76B | 2,376.18B | 2,110.82B | 1,970.11B | 1,707.61B | 1,437.67B | 1,310.24B | 1,172.97B | 973.21B | 836.96B | 1,010.93B |
| Cost of Revenue | 3,073.70B | 2,931.20B | 2,747.09B | 2,421.93B | 2,498.00B | 2,166.03B | 1,931.23B | 1,800.87B | 1,550.31B | 1,306.13B | 1,189.78B | 1,068.52B | 885.99B | 756.73B | 916.55B |
| Gross Profit | 289.82B | 269.63B | 241.75B | 221.69B | 228.76B | 210.16B | 179.60B | 169.24B | 157.30B | 131.53B | 120.46B | 104.46B | 87.22B | 80.23B | 94.39B |
| Gross Profit Ratio | 8.62% | 8.42% | 8.09% | 8.39% | 8.39% | 8.84% | 8.51% | 8.59% | 9.21% | 9.15% | 9.19% | 8.91% | 8.96% | 9.59% | 9.34% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 136.78B | 32.02B | 24.73B | 23.10B | 23.99B | 22.05B | 17.94B | 81.44B | 15.14B | 12.96B | 11.74B | 11.01B | 49.89B | 50.41B | 48.45B |
| Selling & Marketing | 56.23B | 25.88B | 28.51B | 27.94B | 27.62B | 22.16B | 21.03B | 39.66B | 12.14B | 10.53B | 9.35B | 9.01B | 20.80B | 16.84B | 16.42B |
| SG&A | 193.01B | 57.90B | 53.24B | 51.04B | 51.61B | 44.20B | 38.97B | 121.09B | 27.28B | 23.49B | 21.09B | 20.02B | 70.69B | 67.26B | 64.87B |
| Other Expenses | -8.59B | 127.35B | 119.68B | 116.88B | 111.87B | 102.85B | 91.32B | 267.05M | 2.08B | 372.51M | 1.84B | 1.11B | -451.80M | -1.50B | -3.64B |
| Operating Expenses | 184.42B | 185.25B | 172.92B | 167.92B | 163.48B | 146.84B | 129.78B | 121.36B | 114.86B | 97.96B | 89.29B | 80.34B | 70.24B | 67.26B | 64.87B |
| Cost & Expenses | 3,258.12B | 3,116.45B | 2,920.02B | 2,589.85B | 2,661.48B | 2,312.86B | 2,061.01B | 1,922.23B | 1,665.17B | 1,404.09B | 1,279.07B | 1,148.86B | 956.23B | 823.99B | 981.42B |
| Interest Income | 139.72M | 984.05M | 80.14M | 84.15M | 94.75M | 148.65M | 136.95M | 117.91M | 568.77M | 348.37M | 271.03M | 307.35M | 282.50M | 271.09M | 237.24M |
| Interest Expense | 57.58B | 38.48B | 39.89B | 45.12B | 52.89B | 34.66B | 28.78B | 30.75B | 26.30B | 21.95B | 13.74B | 9.98B | 11.14B | 10.35B | 9.72B |
| Depreciation & Amortization | 18.97B | 16.53B | 15.79B | 15.48B | 5.86B | 4.72B | 4.46B | 5.27B | 5.26B | 4.75B | 3.81B | 3.42B | 282.50M | -517.53M | -3.43B |
| EBITDA | 124.51B | 91.48B | 73.60B | 68.34B | 70.47B | 67.98B | 53.92B | 53.27B | 48.28B | 36.97B | 32.99B | 26.67B | 20.43B | 12.61B | 26.30B |
| EBITDA Ratio | 3.70% | 3.18% | 2.83% | 2.62% | 2.61% | 2.87% | 2.58% | 2.44% | 2.83% | 2.69% | 2.69% | 2.37% | 1.77% | 1.49% | 2.58% |
| Operating Income | 105.40B | 73.96B | 57.74B | 52.77B | 64.77B | 63.11B | 49.32B | 47.88B | 42.50B | 31.85B | 28.91B | 22.94B | 16.98B | 12.98B | 29.51B |
| Operating Income Ratio | 3.13% | 2.31% | 1.93% | 2.00% | 2.38% | 2.66% | 2.34% | 2.43% | 2.49% | 2.22% | 2.21% | 1.96% | 1.74% | 1.55% | 2.92% |
| Total Other Income/Expenses | -57.44B | -37.50B | -39.81B | -45.03B | -52.80B | -34.51B | -28.65B | -30.63B | -25.73B | -21.60B | -13.47B | -9.67B | -10.86B | -10.08B | -12.92B |
| Income Before Tax | 47.96B | 36.46B | 17.92B | 7.74B | 11.97B | 28.59B | 20.67B | 17.25B | 16.77B | 10.25B | 15.44B | 13.26B | 6.12B | 2.26B | 16.59B |
| Income Before Tax Ratio | 1.43% | 1.14% | 0.60% | 0.29% | 0.44% | 1.20% | 0.98% | 0.88% | 0.98% | 0.71% | 1.18% | 1.13% | 0.63% | 0.27% | 1.64% |
| Income Tax Expense | 14.88B | 12.00B | 8.35B | 4.94B | 4.09B | 9.15B | 6.49B | 6.14B | 4.87B | 2.93B | 5.20B | 3.42B | 2.11B | 748.62M | 7.08B |
| Net Income | 33.09B | 24.46B | 9.57B | 2.80B | 7.88B | 19.44B | 14.18B | 11.11B | 11.91B | 7.32B | 10.25B | 9.85B | 4.00B | 1.51B | 9.51B |
| Net Income Ratio | 0.98% | 0.76% | 0.32% | 0.11% | 0.29% | 0.82% | 0.67% | 0.56% | 0.70% | 0.51% | 0.78% | 0.84% | 0.41% | 0.18% | 0.94% |
| EPS | 25.97 | 19.20 | 7.51 | 2.20 | 6.19 | 15.26 | 18.89 | 14.98 | 16.06 | 9.89 | 13.81 | 13.27 | 4.91 | 1.96 | 12.76 |
| EPS Diluted | 25.97 | 19.20 | 7.51 | 2.20 | 6.19 | 15.26 | 18.89 | 14.98 | 16.06 | 9.89 | 13.81 | 13.27 | 4.91 | 1.96 | 12.76 |
| Weighted Avg Shares Out | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 750.75M | 728.00M | 728.00M | 728.00M | 728.00M | 728.00M | 741.82M | 741.82M | 741.82M |
| Weighted Avg Shares Out (Dil) | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 1.27B | 750.75M | 741.82M | 741.82M | 741.82M | 741.82M | 741.82M | 741.82M | 741.82M | 741.82M |
Source: https://incomestatements.info
Category: Stock Reports